#startup-evaluation

#startup-evaluation

Antioch aims to close the sim-to-real gap, addressing the challenge of making virtual environments realistic enough for robots to operate reliably in the physical world.

The real breakthrough isn't just using better AI models, but in giving those models deep, structured understanding of how an organization functions, making reliable detection and automated response possible.

No one wants to write a shitty code base. You want healthy code. And so, what founders don't realize is, when you're not taking care of your health, you are shitty code. You are not beautiful code.

Dhruv Amin stated, 'We built a mobile app primarily to let our users who are building iOS apps preview their own app on their own device while developing it. [We] had no problems through December. Post December, we and everyone else in the category started getting our updates blocked.'

"When I'm irritated, tired, stressed, or anxious, a nap literally cures everything. It really changed my life."

In March 2026, US startups raised $19.06 billion across 630 deals, a significant decline of 64.4% year-over-year from March 2025's $53.5 billion, which was heavily influenced by OpenAI's $40 billion mega-round.

Inertia Enterprises burst onto the scene in February with a $450 million Series A, making it one of the best capitalized startups in the industry, aiming to bring laser-based fusion reactors to market.

Goldman Sachs' Chief Equity Strategist Peter Oppenheimer has called the recent sell-off in U.S. tech stocks a rare 'buying opportunity,' suggesting that the current market conditions may favor investment in this sector.

"Claude has regressed to the point it cannot be trusted to perform complex engineering," an AMD senior director wrote in a widely shared post on GitHub.

Austin Nasso rebranded himself as a tech-savvy 'bro' comedian, attracting Silicon Valley's edge lords while maintaining a good-hearted and fun comedic style.

"We were considering multiple forms of capital when we started. It just felt like the opportunity is so large that venture capital gives us the opportunity to take those risks upfront and have the possibility to generate an outsized return."

Helical's thesis is that bio foundation models, AI systems trained on vast genomic, transcriptomic, and proteomic datasets, have already crossed a quality threshold that makes computational hypothesis-testing meaningful in pharma research.

Awards may be encouraging and occasionally useful for visibility, but they are weak indicators of validation and poor predictors of long-term success. In the longevity and healthspan industry, where timelines are long and claims are easy to overstate, venture capital ultimately follows alignment and evidence, not applause received at glitzy industry events.

ADIN uses AI to replace the human analysts involved in venture dealmaking. Put in a startup's pitch deck, and out comes a detailed analysis of its business model and founding team, a list of diligence questions and compliance risks, an estimate of the total addressable market, and a suggested valuation. ADIN has about a dozen different agentic investors, each with a distinct persona and investing thesis.

Because startups typically don't have a track record of success to attract potential clients, they can offer a trial of their platform for free or at a lower cost to showcase what their platform can do and how reliable it is. The enterprise - a potential client - can test the newest technologies without the worry of committing to a complete and often costly rollout.

But he'd been considering an idea for new technology-an autonomous, wind-powered cargo ship. Then, while on paternity leave in 2024, he discovered a free program that helps scientists and engineers launch businesses for the first time. Weeks after finishing the program, called 5050, Cymbalist had launched a startup called Clippership. The company's first ship is being built in the Netherlands this year. Without the accelerator, he says, the company likely wouldn't exist.